Increased concentrations of IL-6 contribute to hypertriglyceridemia and increased LDL cholesterol levels by inhibiting hepatic lipoprotein lipase activity, stimulating triglyceride synthesis, and enhancing lipolysis in adipose tissue. The gene discussed is LPL; the disease is hypertriglyceridemia.